Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
S Afr Med J ; 109(2): 91-94, 2019 Jan 31.
Artigo em Inglês | MEDLINE | ID: mdl-30834858

RESUMO

An atypical case of Crimean-Congo haemorrhagic fever is presented. The diagnosis of the case in the presence of several comorbidities was complicated and illustrates the importance of maintaining a high index of suspicion for viral haemorrhagic fever in cases presenting with multisystem disease and an epidemiological history that could present opportunities for exposure to a haemorrhagic fever virus.


Assuntos
Febre Hemorrágica da Crimeia/diagnóstico , Acidose/diagnóstico , Comorbidade , Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus Tipo 2/epidemiologia , Cetoacidose Diabética/diagnóstico , Diagnóstico Diferencial , Overdose de Drogas/diagnóstico , Cefaleia/etiologia , Febre Hemorrágica da Crimeia/complicações , Febre Hemorrágica da Crimeia/epidemiologia , Humanos , Hipertensão/epidemiologia , Hipoglicemiantes/intoxicação , Masculino , Metformina/intoxicação , Pessoa de Meia-Idade , Mialgia/etiologia , Obesidade/epidemiologia , Hiperplasia Prostática/epidemiologia , Trombocitopenia/etiologia
2.
SAR QSAR Environ Res ; 29(8): 591-611, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-30052064

RESUMO

Results from the Ames test are the first outcome considered to assess the possible mutagenicity of substances. Many QSAR models and structural alerts are available to predict this endpoint. From a regulatory point of view, the recommendation from international authorities is to consider the predictions of more than one model and to combine results in order to develop conclusions about the mutagenicity risk posed by chemicals. However, the results of those models are often conflicting, and the existing inconsistency in the predictions requires intelligent strategies to integrate them. In our study, we evaluated different strategies for combining results of models for Ames mutagenicity, starting from a set of 10 diverse individual models, each built on a dataset of around 6000 compounds. The novelty of our study is that we collected a much larger set of about 18,000 compounds and used the new data to build a family of integrated models. These integrations used probabilistic approaches, decision theory, machine learning, and voting strategies in the integration scheme. Results are discussed considering balanced or conservative perspectives, regarding the possible uses for different purposes, including screening of large collection of substances for prioritization.


Assuntos
Modelos Moleculares , Testes de Mutagenicidade , Relação Estrutura-Atividade , Simulação por Computador , Relação Quantitativa Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA